학술논문
Cardiovascular Outcomes in De Novo Kidney Transplant Recipients Receiving Everolimus and Reduced Calcineurin Inhibitor or Standard Triple Therapy: 24-month Post Hoc Analysis From TRANSFORM Study
Document Type
Article
Author
Source
Transplantation; July 2023, Vol. 107 Issue: 7 p1593-1604, 12p
Subject
Language
ISSN
00411337; 15346080